Phospholipids

Global Soy Lecithin Market Forecast to 2025 - Drivers, Constraints and Challenges - ResearchAndMarkets.com

Retrieved on: 
Monday, June 15, 2020
Food, Beverage, Retail, Domesticated plants, Crops, Branches of biology, Cholinergics, Lecithin, Membrane biology, Nootropics, Phospholipids, Soybean

The wide and constantly increasing product category for Lecithin applications is a healthy sign for the budding demand of soy lecithin market.

Key Points: 
  • The wide and constantly increasing product category for Lecithin applications is a healthy sign for the budding demand of soy lecithin market.
  • Asia-Pacific was followed by North America and Europe as second and third largest market for soy lecithin market.
  • This report identifies the global soy lecithin market size in for the year 2016-2020, and forecast of the same for year 2025.
  • It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global soy lecithin market.

Helsinn Group announces FDA approval of a new liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) injection in the United States

Retrieved on: 
Tuesday, June 2, 2020
Drugs, Antiemetics, Health, Medicine, 5-HT3 antagonists, RTT, Membrane biology, Phospholipids, Netupitant/palonosetron, Palonosetron, Netupitant, Lecithin

AKYNZEO injection does not contain polysorbate 80 or allergenic excipients such as soy or egg lecithin.

Key Points: 
  • AKYNZEO injection does not contain polysorbate 80 or allergenic excipients such as soy or egg lecithin.
  • Riccardo Braglia, Helsinn Group Vice Chairman and CEO, commented: We are pleased to announce FDAs approval of the liquid formulation of AKYNZEO.
  • AKYNZEO (fosnetupitant 235mg/palonosetron 0.25) for injection was approved in April 2018 and AKYNZEO injection was approved in May 2020 in the United States.
  • AKYNZEO for injection and AKYNZEO injection have not been studied for the prevention of nausea and vomiting associated with anthracycline plus cyclophosphamide chemotherapy.

Sesderma Laboratories Communicates the Effectiveness of Lactyferrin Forte Solution in Boosting Immunity

Retrieved on: 
Friday, April 17, 2020
Cholinergics, Branches of biology, Phospholipids, Health, Contents, Membrane biology, Quaternary ammonium compounds, Choline, Lecithin, Virus, Phosphatidylcholine, HIV/AIDS

The company has named this combination as Lactyferrin.

Key Points: 
  • The company has named this combination as Lactyferrin.
  • Lactyferrin can also suppress replication of the virus after the virus enters the cell as in the case of AIDS (Puddu et al, 1998).
  • Since liposome is made of soy lecithin (phosphatidyl choline), LF is biodegradable and biocompatible, which means it is very safe.
  • For more information about Sesderma and Lactyferrin, visit https://www.sesderma.com/es_es/home

Sesderma Laboratories Communicates the Effectiveness of Lactyferrin Forte Solution in Boosting Immunity

Retrieved on: 
Friday, April 17, 2020
Cholinergics, Branches of biology, Phospholipids, Health, Contents, Membrane biology, Lecithin, Nootropics, Choline, Phosphatidylcholine, Virus, HIV/AIDS

The company has named this combination as Lactyferrin.

Key Points: 

Global Genetically and Non-Genetically Modified Lecithin Market (2020 to 2026) - Latest Market News and Developments - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 19, 2020
Chemicals, Plastics, Manufacturing, Branches of biology, Articles, Biology, Membrane biology, Phospholipids, Emerging technologies, Cholinergics, Lecithin, Nootropics, Genetic engineering

Global Genetically and non-Genetically Modified Lecithin industry size outlook, 2020-2026

Key Points: 
  • Global Genetically and non-Genetically Modified Lecithin industry size outlook, 2020-2026
    Types of Genetically and non-Genetically Modified Lecithin, 2020-2026
    Genetically and non-Genetically Modified Lecithin applications and end-user verticals market size, 2020-2026
    Genetically and non-Genetically Modified Lecithin market size across countries, 2020-2026
    5 leading companies in the industry-overview, SWOT, financials, and products
    2.
  • Genetically and non-Genetically Modified Lecithin Market Trends, Outlook and Business Prospects, 2020-2026
    2.3 Emerging Genetically and non-Genetically Modified Lecithin Market Trends, 2020-2026
    2.3.1 Fast growing Genetically and non-Genetically Modified Lecithin types, 2020-2026
    2.3.2 Fast growing Genetically and non-Genetically Modified Lecithin application industry, 2020-2026
    2.3.3 Most promising countries for Genetically and non-Genetically Modified Lecithin sales, 2020-2026
    2.5.1 Genetically and non-Genetically Modified Lecithin Industry Attractiveness Index, 2020
    3.
  • Global Genetically and non-Genetically Modified Lecithin Market Size, Share and Outlook to 2026
    3.1 Global Genetically and non-Genetically Modified Lecithin Market Value Outlook, 2020-2026
    3.2 Global Genetically and non-Genetically Modified Lecithin Market Size and Share Outlook by Type, 2020-2026
    3.3 Global Genetically and non-Genetically Modified Lecithin Market Size and Share Outlook by Application, 2020-2026
    3.4 Global Genetically and non-Genetically Modified Lecithin Market Size and Share Outlook by Region, 2020-2026
    4.
  • Asia Pacific Genetically and non-Genetically Modified Lecithin Market Size, Share and Outlook to 2026
    4.1 Asia Pacific Genetically and non-Genetically Modified Lecithin Market Value Outlook, 2020-2026
    4.2 Asia Pacific Genetically and non-Genetically Modified Lecithin Market Size and Share Outlook by Type, 2020-2026
    4.3 Asia Pacific Genetically and non-Genetically Modified Lecithin Market Size and Share Outlook by Application, 2020-2026
    4.4 Asia Pacific Genetically and non-Genetically Modified Lecithin Market Size and Share Outlook by Country, 2020-2026
    5.

2020 Global De-oiled Lecithin Market: Drivers, Restraints, Opportunities & Trends - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 11, 2020
Fitness & Nutrition, Health, Branches of biology, Phospholipids, Membrane biology, Cholinergics, Lecithin, Nootropics, Cell biology

The "2020 Global De-oiled Lecithin Market, Size, Share, Outlook and Growth Opportunities, Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2020 Global De-oiled Lecithin Market, Size, Share, Outlook and Growth Opportunities, Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • Increasing family disposable incomes coupled with strengthening buyer power will support the De-oiled Lecithin market growth between 2020 and 2026.
  • The report 2020 Global De-oiled Lecithin Market, Size, Share, Outlook and Growth Opportunities' is a comprehensive work on the De-oiled Lecithin markets, companies, types, applications, and end-user verticals.
  • Global De-oiled Lecithin industry size outlook, 2020-2026
    De-oiled Lecithin applications and end-user verticals market size, 2020-2026
    De-oiled Lecithin market size across countries, 2020-2026
    5 leading companies in the industry-overview, SWOT, financials, and products

Egg Yolk Lecithin Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029

Retrieved on: 
Wednesday, March 4, 2020
Branches of biology, Phospholipids, Reproduction, Cholinergics, Membrane biology, Animal sexuality, Lecithin, Nootropics, Egg as food, Yolk, Egg

Egg Yolk Lecithin Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029

Key Points: 
  • Egg Yolk Lecithin Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029
    The global egg yolk lecithin market is contemplating a profound rise in the forecast period 2019 to 2029, according to the study.
  • The global egg yolk lecithin market report is an intricate market intelligence on key growth determinants, challenges, market trends and opportunities, which will eventually influence the rising graph for the global egg yolk lecithin market.
  • Global Egg Yolk Lecithin Market: Report Summary and Scope
    The study cites a detailed intelligence on factors influencing the demand, sales and revenue generation within the global egg yolk lecithin market.
  • Global Egg Yolk Lecithin Market: In-depth Analysis on Competitive Landscape
    The report concludes with a weighted chapter on the competition landscape on the global egg yolk lecithin market, which profiles key companies contributing to the market.

Global Lecithin & Phospholipids Market, Size, Share, Outlook, Growth Opportunities & Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 20, 2020
Chemicals, Plastics, Manufacturing, Branches of biology, Phospholipids, Membrane biology, Cholinergics, Lecithin, Nootropics, Colloidal chemistry, Chemistry

The "2020 Global Lecithin and Phospholipids Market, Size, Share, Outlook and Growth Opportunities, Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2020 Global Lecithin and Phospholipids Market, Size, Share, Outlook and Growth Opportunities, Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • Increasing family disposable incomes coupled with strengthening buyer power will support the Lecithin and Phospholipids market growth between 2020 and 2026.
  • The report 2020 Global Lecithin and Phospholipids Market, Size, Share, Outlook and Growth Opportunities' is a comprehensive work on the Lecithin and Phospholipids markets, companies, types, applications, and end-user verticals.
  • Global Lecithin and Phospholipids industry size outlook, 2020-2026
    Types of Lecithin and Phospholipids, 2020-2026
    Lecithin and Phospholipids applications and end-user verticals market size, 2020-2026
    Lecithin and Phospholipids market size across countries, 2020-2026
    5 leading companies in the industry-overview, SWOT, financials, and products

Next Wave of Growth Opportunities in the De-oiled Lecithin Market 2020- 2026

Retrieved on: 
Monday, February 17, 2020
Branches of biology, Phospholipids, Membrane biology, Cholinergics, Lecithin, Nootropics, Market research, Cell biology

DUBLIN, Feb. 17, 2020 /PRNewswire/ -- The "2020 Global De-oiled Lecithin Market, Size, Share, Outlook and Growth Opportunities, Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 17, 2020 /PRNewswire/ -- The "2020 Global De-oiled Lecithin Market, Size, Share, Outlook and Growth Opportunities, Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The report 2020 Global De-oiled Lecithin Market, Size, Share, Outlook and Growth Opportunities' is a comprehensive work on the De-oiled Lecithin markets, companies, types, applications, and end-user verticals.
  • Global De-oiled Lecithin industry size outlook, 2020-2026
    De-oiled Lecithin applications and end-user verticals market size, 2020-2026
    De-oiled Lecithin market size across countries, 2020-2026
    5 leading companies in the industry-overview, SWOT, financials, and products
    2.3 Emerging De-oiled Lecithin Market Trends, 2020-2026
    3.
  • Middle East Africa De-oiled Lecithin Market Size, Share and Outlook to 2026
    ResearchAndMarkets.com is the world's leading source for international market research reports and market data.

Sanofi : Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency

Retrieved on: 
Thursday, January 30, 2020
Health, Branches of biology, Clinical research, Medicine, Membrane biology, Phospholipids, Sphingomyelin, Clinical trial, Placebo

Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency

Key Points: 
  • Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency
    Acid sphingomyelinase deficiency (ASMD) is a rare, progressive and potentially life-threatening disease for which no treatments are approved
    PARIS January 30, 2020 Olipudase alfa, an investigational recombinant human acid sphingomyelinase, demonstrated positive results in two separate clinical trials evaluating olipudase alfa for the treatment of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients.
  • Olipudase alfa is the first and only investigational enzyme replacement therapy in late-stage development for the treatment of ASMD.
  • The relative improvement from baseline to week 52 was 22% for the olipudase alfa arm compared with 3% for the placebo arm.
  • In the olipudase alfa arm, spleen volume was reduced by 39.5%, compared with a 0.5% increase in the placebo arm.